Published in Rheumatol Int on October 30, 2010
Evaluation of the Temporal Association between Kawasaki Disease and Viral Infections in South Korea. Korean Circ J (2014) 0.88
Adult-onset Kawasaki disease (mucocutaneous lymph node syndrome) and concurrent Coxsackievirus A4 infection: a case report. Int Med Case Rep J (2015) 0.80
A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics (1974) 9.97
Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet (1993) 4.06
Association between a novel human coronavirus and Kawasaki disease. J Infect Dis (2005) 3.71
Active or recent parvovirus B19 infection in children with Kawasaki disease. Lancet (1994) 2.32
Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int (2005) 2.30
Kawasaki disease: what is the epidemiology telling us about the etiology? Int J Infect Dis (2005) 1.93
Blinded case-control study of the relationship between human coronavirus NL63 and Kawasaki syndrome. J Infect Dis (2006) 1.81
Kawasaki disease associated with streptococcal infection within a family. J Paediatr Child Health (1995) 1.61
Kawasaki disease. Curr Opin Rheumatol (2006) 1.42
Infections and Kawasaki disease: implications for coronary artery outcome. Pediatrics (2005) 1.24
Variant strain of Propionibacterium acnes: a clue to the aetiology of Kawasaki disease. Lancet (1983) 1.19
New developments in the search for the etiologic agent of Kawasaki disease. Curr Opin Pediatr (2007) 1.14
The Coxsackie viruses. Annu Rev Microbiol (1955) 1.13
Responsiveness to intravenous immunoglobulins and occurrence of coronary artery abnormalities in a single-center cohort of Italian patients with Kawasaki syndrome. Rheumatol Int (2010) 1.10
Outbreak of life-threatening coxsackievirus B1 myocarditis in neonates. Clin Infect Dis (2009) 1.05
Current recommendations for the pharmacologic therapy in Kawasaki syndrome and management of its cardiovascular complications. Eur Rev Med Pharmacol Sci (2007) 1.04
The role of superantigens of group A Streptococcus and Staphylococcus aureus in Kawasaki disease. Curr Opin Infect Dis (2007) 1.04
Kawasaki disease may be a hyperimmune reaction of genetically susceptible children to variants of normal environmental flora. Med Hypotheses (2007) 1.04
A case of Kawasaki disease with coronary artery aneurysms documenting Yersinia pseudotuberculosis infection. Acta Paediatr (1997) 1.00
Primary cytomegalovirus infection, atypical Kawasaki disease, and coronary aneurysms in 2 infants. Clin Infect Dis (2005) 0.88
Kawasaki syndrome-like illness associated with infection caused by enterotoxin B-secreting Staphylococcus aureus. Clin Infect Dis (1999) 0.87
Cytomegalovirus infection in a patient with atypical Kawasaki disease. Rheumatol Int (2007) 0.84
Kawasaki syndrome associated with group A streptococcal and Epstein-Barr virus co-infections. Ann Trop Paediatr (2002) 0.83
Mycoplasma pneumoniae infection associated with Kawasaki disease. Acta Paediatr (2001) 0.79
Is there an association between Kawasaki disease and Chlamydia pneumoniae? J Infect Dis (2000) 0.77
Diagnosis of Coxsackie enterovirus infections by serum complement fixation tests. Br J Clin Pract (1976) 0.75
EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis (2010) 3.47
Rare NLRP12 variants associated with the NLRP12-autoinflammatory disorder phenotype: an Italian case series. Clin Exp Rheumatol (2013) 2.09
Results from a multicentre international registry of familial Mediterranean fever: impact of environment on the expression of a monogenic disease in children. Ann Rheum Dis (2013) 2.09
Effect of amplitude and inspiratory time in a bench model of non-invasive HFOV through nasal prongs. Pediatr Pulmonol (2012) 2.02
Mevalonate kinase genotype in children with recurrent fevers and high serum IgD level. Rheumatol Int (2012) 1.95
Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series. Arthritis Rheum (2011) 1.79
Acute necrotizing encephalopathy during novel influenza A (H1N1) virus infection. Ann Neurol (2010) 1.64
Innate immunity of the human newborn is polarized toward a high ratio of IL-6/TNF-alpha production in vitro and in vivo. Pediatr Res (2006) 1.59
Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review. Ann Rheum Dis (2012) 1.59
Prognostic factors and outcome of children with severe head injury: an 8-year experience. Childs Nerv Syst (2002) 1.47
Serum amyloid-A in Behçet's disease. Clin Rheumatol (2014) 1.47
Systematic review and meta-analysis of currently available clinical evidence on migraine and patent foramen ovale percutaneous closure: much ado about nothing? Catheter Cardiovasc Interv (2010) 1.45
Spontaneous fatal intracranial hemorrhage in a child with Evans syndrome. Pediatr Hematol Oncol (2003) 1.42
Fatal coronary artery anomaly presenting as bronchiolitis. Eur J Pediatr (2005) 1.41
Transcatheter closure of atrial septal defect in young children: results and follow-up. J Am Coll Cardiol (2003) 1.25
Interleukin 1beta and interleukin 6 relationship with paediatric head trauma severity and outcome. Childs Nerv Syst (2004) 1.16
Mechanisms of action of spa therapies in rheumatic diseases: what scientific evidence is there? Rheumatol Int (2010) 1.14
The systemic-onset variant of juvenile idiopathic arthritis needs to be recorded as an autoinflammatory syndrome: comment on the review by Nigrovic. Arthritis Rheumatol (2014) 1.12
Efficacy of anakinra in refractory Behçet's disease sacroiliitis. Clin Exp Rheumatol (2014) 1.12
Responsiveness to intravenous immunoglobulins and occurrence of coronary artery abnormalities in a single-center cohort of Italian patients with Kawasaki syndrome. Rheumatol Int (2010) 1.10
Levosimendan in two neonates with ischemic heart failure and pulmonary hypertension. Neonatology (2011) 1.08
Catecholaminergic polymorphic ventricular tachycardia: successful emergency treatment with intravenous propranolol. Pediatr Emerg Care (2004) 1.02
Safety and efficacy of etanercept in a cohort of patients with juvenile idiopathic arthritis under 4 years of age. J Rheumatol (2012) 1.02
Electrical and autonomic cardiac function in patients with Dravet syndrome. Epilepsia (2011) 1.01
Bile acids cause secretory phospholipase A2 activity enhancement, revertible by exogenous surfactant administration. Intensive Care Med (2008) 1.01
First report of macrophage activation syndrome in hyperimmunoglobulinemia D with periodic fever syndrome. Arthritis Rheum (2007) 0.99
Serious Pseudomonas aeruginosa infection in healthy children: case report and review of the literature. Pediatr Int (2006) 0.99
Management of status dystonicus: our experience and review of the literature. Mov Disord (2007) 0.99
The use of the Berlin definition for acute respiratory distress syndrome during infancy and early childhood: multicenter evaluation and expert consensus. Intensive Care Med (2013) 0.99
The potential role of bone scintigraphy in the detection of deep muscular fascia involvement and calcinosis cutis in anti-synthetase syndrome. Int J Rheum Dis (2013) 0.98
Correlation between neurotrophic factor expression and outcome of children with severe traumatic brain injury. Intensive Care Med (2003) 0.98
A twenty-year retrospective study of pediatric tuberculosis in two tertiary hospitals in Rome. Pediatr Infect Dis J (2012) 0.95
The impact of initial management on the outcome of children with severe head injury. Childs Nerv Syst (2001) 0.94
Inhibition of interleukin-1 by canakinumab as a successful mono-drug strategy for the treatment of refractory Behçet's disease: a case series. Dermatology (2014) 0.94
Biological treatments: new weapons in the management of monogenic autoinflammatory disorders. Mediators Inflamm (2013) 0.93
Differential diagnosis between patent foramen ovale and pulmonary arteriovenous fistula in two patients with previous cryptogenic stroke caused by presumed paradoxical embolism. J Am Soc Echocardiogr (2002) 0.93
Exercise-unrelated sudden death as the first event of anomalous origin of the left coronary artery from the right aortic sinus. J Emerg Med (2005) 0.92
Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome. Clin Rheumatol (2014) 0.91
Monogenic autoinflammatory syndromes: state of the art on genetic, clinical, and therapeutic issues. Int J Rheumatol (2013) 0.91
Current therapeutic approaches to autoimmune chronic uveitis in children. Autoimmun Rev (2010) 0.90
Role of heart rate variability in the early diagnosis of diabetic autonomic neuropathy in children. Herz (2002) 0.90
Neuroprotection and hypothermia in infants and children. Curr Drug Targets (2012) 0.90
Long-term clinical course of patients carrying the Q703K mutation in the NLRP3 gene: a case series. Clin Exp Rheumatol (2012) 0.90
A case of resistant adult-onset periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) syndrome responsive to anakinra. Clin Exp Rheumatol (2012) 0.89
Short- and long-term effects of spa therapy in knee osteoarthritis. Am J Phys Med Rehabil (2010) 0.88
Successful treatment of tumor necrosis factor receptor-associated periodic syndrome with canakinumab. Ann Intern Med (2012) 0.88
Secretory phospholipase A₂ pathway during pediatric acute respiratory distress syndrome: a preliminary study. Pediatr Crit Care Med (2011) 0.88
Safety issues and concerns of new immunomodulators in rheumatology. Expert Opin Drug Saf (2014) 0.88
Noninvasive high frequency oscillatory ventilation through nasal prongs: bench evaluation of efficacy and mechanics. Intensive Care Med (2010) 0.88
Post-inflammatory retinal dystrophy in CINCA syndrome. Rheumatol Int (2009) 0.88
The use of TNF-α blockers in psoriatic arthritis patients with latent tuberculosis infection. Clin Rheumatol (2014) 0.87
Effects of spa therapy on serum leptin and adiponectin levels in patients with knee osteoarthritis. Rheumatol Int (2010) 0.87
Long-term response after 6-year treatment with anakinra and onset of focal bone erosion in neonatal-onset multisystem inflammatory disease (NOMID/CINCA). Rheumatol Int (2011) 0.87
Cardiac tamponade and bilateral pleural effusion in a very low birth weight infant. J Matern Fetal Neonatal Med (2009) 0.87
Registries in rheumatological and musculoskeletal conditions. Paediatric Behçet's disease: an international cohort study of 110 patients. One-year follow-up data. Rheumatology (Oxford) (2010) 0.87
Utility of intranasal Ketamine and Midazolam to perform gastric aspirates in children: a double-blind, placebo controlled, randomized study. BMC Pediatr (2014) 0.87
Neurogenic stunned myocardium presenting as left ventricular hypertrabeculation in childhood: a variant of Takotsubo cardiomyopathy? Pediatr Crit Care Med (2011) 0.86
Involvement of X-box binding protein 1 and reactive oxygen species pathways in the pathogenesis of tumour necrosis factor receptor-associated periodic syndrome. Ann Rheum Dis (2012) 0.86
Role of distinct phospholipases A2 and their modulators in meconium aspiration syndrome in human neonates. Intensive Care Med (2011) 0.86
Renal involvement in secondary amyloidosis of Muckle-Wells syndrome: marked improvement of renal function and reduction of proteinuria after therapy with human anti-interleukin-1β monoclonal antibody canakinumab. Clin Rheumatol (2014) 0.86
Recurrent pericarditis: autoimmune or autoinflammatory? Autoimmun Rev (2012) 0.86
From the Mediterranean to the sea of Japan: the transcontinental odyssey of autoinflammatory diseases. Biomed Res Int (2013) 0.85
Sudden shock from capillary leak. Lancet (2012) 0.85
Neonatal emergencies associated with cardiac rhabdomyomas: an 8-year experience. Fetal Diagn Ther (2010) 0.85
Myocardial performance index and biochemical markers for early detection of doxorubicin-induced cardiotoxicity in children with acute lymphoblastic leukaemia. Int J Clin Oncol (2012) 0.85
Treatment strategies for childhood noninfectious chronic uveitis: an update. Expert Opin Investig Drugs (2011) 0.85
Malignant hypertension and cerebral haemorrhage in Seckel syndrome. Eur J Pediatr (2003) 0.84
The diagnostic evaluation of patients with potential adult-onset autoinflammatory disorders: our experience and review of the literature. Autoimmun Rev (2012) 0.84
Autoinflammatory diseases and cardiovascular manifestations. Ann Med (2011) 0.84
Early-onset sarcoidosis caused by a rare CARD15/NOD2 de novo mutation and responsive to infliximab: a case report with long-term follow-up and review of the literature. Clin Rheumatol (2014) 0.83
First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS). PLoS One (2013) 0.83
Neurotrophic factor expression in childhood low-grade astrocytomas and ependymomas. Childs Nerv Syst (2004) 0.83
Priming of hematopoietic progenitor cells by plerixafor and filgrastim in children with previous failure of mobilization with chemotherapy and/or cytokine treatment. J Pediatr Hematol Oncol (2012) 0.83
Interleukin-1 Inhibition in Behçet's disease. Isr Med Assoc J (2016) 0.83
Atypical manifestations of congenital parvovirus B19 infection. Eur J Pediatr (2008) 0.82
Macrophage activation syndrome in the course of monogenic autoinflammatory disorders. Clin Rheumatol (2015) 0.82
Intraventricular nerve growth factor infusion: a possible treatment for neurological deficits following hypoxic-ischemic brain injury in infants. Neurol Res (2005) 0.82
Involvement of type I immune responses in swine-origin H1N1 influenza virus infection. Hum Immunol (2011) 0.82
Interleukin and neurotrophin up-regulation correlates with severity of H1N1 infection in children: a case-control study. Int J Infect Dis (2013) 0.82
Secretory phospholipase A2 and neonatal respiratory distress: pilot study on broncho-alveolar lavage. Intensive Care Med (2008) 0.82
Clinical and biological role of secretory phospholipase A2 in acute respiratory distress syndrome infants. Crit Care (2013) 0.81
Antiangiogenic VEGF isoform in inflammatory myopathies. Mediators Inflamm (2013) 0.81
Anakinra treatment in patients with gout and type 2 diabetes. Clin Rheumatol (2014) 0.81